Related Experiment Video
Updated: Jun 13, 2026
Anesthesia and Intubation of Preadolescent Mouse Pups for Cardiothoracic Surgery
Published on: June 2, 2022
Effect of increasing depth of dexmedetomidine anesthesia on upper airway morphology in children
Mohamed Mahmoud1, Rupa Radhakrishman, Joel Gunter
1Department of Anesthesiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA. mohamed.mahmoud@cchmc.org
Insights
Increasing doses of dexmedetomidine (a sedative) caused minor changes in the upper airway of children without obstructive sleep apnea (OSA). These small, dose-dependent effects did not lead to clinical signs of airway obstruction.
Area of Science:
- Pediatric Anesthesiology
- Respiratory Physiology
- Medical Imaging
Background:
- Sedatives like dexmedetomidine can affect upper airway muscle activity, potentially leading to obstruction.
- The dose-response effects of dexmedetomidine on pediatric upper airways are not well understood.
- This study investigated these effects in children without obstructive sleep apnea (OSA).
Purpose of the Study:
- To evaluate the impact of increasing dexmedetomidine doses on upper airway morphology.
- To assess static and dynamic changes in the upper airway using magnetic resonance (MR) imaging.
- To determine if these changes correlate with airway obstruction in children.
Main Methods:
- Prospective study involving 23 children undergoing brain MR imaging.
- Administration of low (1 mcg/kg/h) and high (3 mcg/kg/h) doses of dexmedetomidine.
- Acquisition of static and dynamic MR images of the upper airway to measure dimensions and collapsibility.
Main Results:
- Retroglossal airway (RGA) static dimensions showed no significant change with increasing dexmedetomidine dose.
- Most sagittal airway measurements exhibited small, statistically significant reductions at higher doses.
- Dynamic changes in airway area during respiration increased slightly, but no airway obstruction was observed.
Conclusions:
- Increasing dexmedetomidine doses in children without OSA cause minimal upper airway changes.
- These minor morphological alterations do not appear to cause clinical airway obstruction.
- Standard precautions for managing airway obstruction are still recommended when using dexmedetomidine for sedation.
Objective:
This prospective study examines the dose-response effects of dexmedetomidine on upper airway morphology in children with no obstructive sleep apnea (OSA).
Aim:
To determine the effect of increasing doses of dexmedetomidine on static and dynamic magnetic resonance (MR) images of the upper airway in spontaneously breathing children with no OSA.
Background:
General anesthetics and sedatives attenuate upper airway muscle activity, rendering the airway vulnerable to obstruction. Dose-response effects of dexmedetomidine on upper airway of children are not known. We prospectively examined the dose-response effects of dexmedetomidine on upper airway morphology in children.
Methods/Materials:
Increasing doses of dexmedetomidine was administered to 23 children scheduled for MR imaging of the brain while breathing spontaneously via the native airway. Static axial and dynamic sagittal midline MR ciné images of the upper airway were obtained during low (1 mcg.kg(-1).h(-1)) and high (3 mcg.kg(-1).h(-1)) doses of dexmedetomidine. The airway anteroposterior diameter, transverse diameter, and cross-sectional areas were measured manually by two independent observers. Static airway measurements were taken at the level of the nasopharyngeal airway (sagittal images) and retroglossal airway (RGA) (sagittal and axial images). Dynamic change in cross-sectional area of airway between inspiration and expiration was considered a measure of airway collapsibility.
Results:
Static axial measurements of RGA did not change with increasing dose of dexmedetomidine. Most sagittal airway dimensions demonstrated clinically modest, although statistically significant, reductions with high dose compared to low dose dexmedetomidine. Although, the dynamic changes in nasopharyngeal and retroglossal area with respiration were marginally greater for high dose than for low dose dexmedetomidine, no subject exhibited any clinical evidence of airway obstruction.
Conclusion:
Upper airway changes associated with increasing doses of dexmedetomidine in children with no OSA are small in magnitude and do not appear to be associated with clinical signs of airway obstruction. Even though these changes are small, all precautions to manage airway obstruction should be taken when dexmedetomidine is used for sedation.
Related Concept Videos
01:22Stages of General Anesthesia
01:20Inhalational Anesthetics: Overview
01:24Parenteral Anesthetics: Overview
01:24General Anesthesia: Overview
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...